Syndrome in question

Costello syndrome (CS) is a rare genetic disorder, first described by Costello in 1971, caused by mutations in the HRAS proto-oncogene. Clinical findings include facial dysmorphism, skin disorders, cognitive impairment, cardiac and musculoskeletal defects. There is an increased risk of malignancies...

Full description

Bibliographic Details
Published in:	Anais Brasileiros de Dermatologia
Main Authors:	Isy Lima Peixoto, Ana Maria Carreno, Vania Mesquita Gadelha Prazeres, Caroline Albuquerque Rodrigues Chirano, Gabriel Maroja Ihara, Patricia Bandeira de Melo Akel
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Dermatologia 2014-12-01
Subjects:	Costello syndrome Genes, ras Proto-oncogenes
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962014000601005&tlng=en

Similar Items

O PROTO-ONCOGENE RAS NO BÓCIO MULTINODULAR
by: Lenara Golbert, et al.
Published: (2022-07-01)

The Effect of <i>RAS2</i> Gene Mutation in Single Cell Yeast Model
by: Nazela Ahmed Chowdhury, et al.
Published: (2023-03-01)

Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review
by: Elena Orlandi, et al.
Published: (2024-05-01)

MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model
by: William E. Tidyman, et al.
Published: (2022-02-01)

Enhanced proliferation in a prawn embryonic primary cell culture ectopically expressing mutated Ras
by: Gurucharan Sudarshan, et al.
Published: (2023-01-01)

The RASopathies: from pathogenetics to therapeutics
by: Katie E. Hebron, et al.
Published: (2022-02-01)

Current Issues in Carcinogenesis
by: IV Vysotskaya, et al.
Published: (2018-12-01)

<i>KRAS</i> G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?
by: Henry Shen, et al.
Published: (2022-10-01)

Use of DNA‐alkylating pyrrole‐imidazole polyamides for anti‐cancer drug sensitivity screening in pancreatic ductal adenocarcinoma
by: Akiko Tsujimoto, et al.
Published: (2023-03-01)

Carcinoma medular de tiroides familiar (CMTF): primera familia descripta con CMTF asociado a la mutación Cys611Trp del proto-oncogen RET*
by: Tomás Fernández Gianotti, et al.
Published: (2025-04-01)

Avaliação da imunomarcação da proteína c-kit (CD-117) em tumores mamários caninos
by: André Rebelo Pantoja, et al.
Published: (2020-03-01)

Expressão dos protooncogenes c-fos, c-myc e c-jun em miométrio normal e mioma humanos Expression of the protooncogenes c-fos, c-myc and c-jun in human normal miometrium and leiomyoma
by: Ana Luiza Ferrari, et al.
Published: (2006-10-01)

Correlation of miR-31 and miR-373 expression with KRAS mutations and its impact on prognosis in colorectal cancer
by: Hasan Ashoori, et al.
Published: (2022-08-01)

Exploration of tumor growth regression of quinoa and chia oil nanocapsules via the control of PIK3CA and MYC expression, anti-inflammation and cell proliferation inhibition, and their hepatorenal safety in rat breast cancer model
by: Aida I. El makawy, et al.
Published: (2024-01-01)

Review papers The role of KIT gene mutations in pathogenesis of pediatric mastocytosis
by: Joanna Dawicka, et al.
Published: (2015-03-01)

Dysplastic Mitral Valve in Costello Syndrome
by: Tamara Naneishvili, MBBS, et al.
Published: (2024-07-01)

Cardiofaciocutaneous Syndrome: Case Report of a Rare Disorder
by: Soutrik Seth, et al.
Published: (2016-11-01)

Costello Syndrome: The Challenge of Hypoglycemia and Failure to Thrive
by: C. Leoni, et al.
Published: (2018-01-01)

Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives
by: Renata Tisi, et al.
Published: (2020-11-01)

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models
by: Nicole J. Chew, et al.
Published: (2021-08-01)

A rare case of medullary carcinoma
by: O.Z. Lishchuk, et al.
Published: (2023-10-01)

Comparative aspects of mast cell neoplasia in animals and the role of KIT in prognosis and treatment
by: Vanessa S. Tamlin, et al.
Published: (2020-02-01)

Prognostic value of increased expression of RBM8A in gastric cancer
by: Xinting Lv, et al.
Published: (2020-04-01)

A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma
by: Mohammadi Masoumeh, et al.
Published: (2016-11-01)

Gastrointestinal stromal tumors (gists): Definition, clinical, histological, immunohistochemical and molecular genetic features and predictors of malignant potential and differential diagnosis
by: Zivković Vesna, et al.
Published: (2002-01-01)

Update on Fundamental Mechanisms of Thyroid Cancer
by: Alessandro Prete, et al.
Published: (2020-03-01)

Molecular Correlates and Nuclear Features of Encapsulated Follicular-Patterned Thyroid Neoplasms
by: Chan Kwon Jung, et al.
Published: (2021-02-01)

Hepatic Tumor as Antenatal Presentation of Costello Syndrome
by: Chusana Petpichetchian, et al.
Published: (2021-03-01)

Treatment of Dystonia Using Trihexyphenidyl in Costello Syndrome
by: Domenico M. Romeo, et al.
Published: (2020-07-01)

MOLECULAR-GENETIC «PORTRAIT» OF BREAST CANCER
by: S. A. Laptiev, et al.
Published: (2017-06-01)

Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal Cancer
by: Błażej Ochman, et al.
Published: (2024-11-01)

Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia Proliferação celular e apoptose em câncer gástrico e metaplasia intestinal
by: Nora Manoukian Forones, et al.
Published: (2005-03-01)

Prognostic factors of neuroblastoma in limited-resource settings
by: Roberta Gomes Ribeiro Gonçalves Pinto, et al.
Published: (2025-07-01)

BRAF V600E Mutation in Odontogenic Keratocyst: A Systematic Review and Meta-Analysis
by: Jéssica da Silva Cunha, et al.
Published: (2025-01-01)

Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review
by: Alfredo Colombo, et al.
Published: (2024-07-01)

DeepCBS: shedding light on the impact of mutations occurring at CTCF binding sites
by: Yiheng Wang, et al.
Published: (2024-02-01)

Excellent treatment outcomes in children younger than 18 months with stage 4 nonamplified neuroblastoma
by: Chiwoo Kim, et al.
Published: (2018-02-01)

An extremely rare case of concurrent BRAF V600E mutation driven hairy cell leukemia and melanoma: case report and review of literature
by: Amir Ghorbani-Aghbolaghia, et al.
Published: (2017-09-01)

BCL11A Promotes the Progression of Laryngeal Squamous Cell Carcinoma
by: Jian Zhou, et al.
Published: (2020-03-01)

The Ins and Outs of RAS Effector Complexes
by: Christina Kiel, et al.
Published: (2021-02-01)